Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Am Chem Soc ; 145(47): 25776-25788, 2023 11 29.
Artigo em Inglês | MEDLINE | ID: mdl-37972287

RESUMO

Misfolded protein oligomers are of central importance in both the diagnosis and treatment of Alzheimer's and Parkinson's diseases. However, accurate high-throughput methods to detect and quantify oligomer populations are still needed. We present here a single-molecule approach for the detection and quantification of oligomeric species. The approach is based on the use of solid-state nanopores and multiplexed DNA barcoding to identify and characterize oligomers from multiple samples. We study α-synuclein oligomers in the presence of several small-molecule inhibitors of α-synuclein aggregation as an illustration of the potential applicability of this method to the development of diagnostic and therapeutic methods for Parkinson's disease.


Assuntos
Nanoporos , Doença de Parkinson , Humanos , alfa-Sinucleína/metabolismo , Doença de Parkinson/metabolismo
2.
PLoS One ; 15(9): e0239813, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32986768

RESUMO

Two systems of antibody-drug conjugates (ADCs), noncleavable H32-DM1 and cleavable H32-VCMMAE, were developed by using different linkers and drugs attached to the anti-HER2 antibody H32, which is capable of cell internalization. Activated functional groups, including an N-hydroxysuccinimidyl (NHS) ester and a maleimide, were utilized to make the ADCs. Mass spectrometry, hydrophobic interaction chromatography, polyacrylamide gel electrophoresis, and in vitro cell assays were performed to analyze and optimize the ADCs. Several H32-VCMMAE ADCs were established with higher DARs and greater synthetic yields without compromising potency. The anticancer efficacy of H32-DM1 was 2- to 8-fold greater than that of Kadcyla®. The efficacy of H32-VCMMAE was in turn better than that of H32-DM1. The anticancer efficacy of these ADCs against N87, SK-BR-3 and BT474 cells was in the following order: H32-VCMMAE series > H32-DM1 series > Kadcyla®. The optimal DAR for H32-VCMMAE was found to be 6.6, with desirable attributes including good cell penetration, a releasable payload in cancer cells, and high potency. Our results demonstrated the potential of H32-VCMMAE as a good ADC candidate.


Assuntos
Anticorpos Monoclonais Humanizados/farmacologia , Neoplasias da Mama/metabolismo , Imunoconjugados/farmacologia , Receptor ErbB-2/imunologia , Receptor ErbB-2/metabolismo , Ado-Trastuzumab Emtansina/química , Ado-Trastuzumab Emtansina/farmacologia , Anticorpos Monoclonais Humanizados/química , Antineoplásicos Imunológicos/química , Antineoplásicos Imunológicos/farmacologia , Neoplasias da Mama/patologia , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Feminino , Humanos , Imunoconjugados/química , Concentração Inibidora 50 , Oligopeptídeos/química , Oligopeptídeos/farmacologia
3.
Bioconjug Chem ; 31(7): 1804-1811, 2020 07 15.
Artigo em Inglês | MEDLINE | ID: mdl-32526138

RESUMO

Linker design is crucial to the success of antibody-drug conjugates (ADCs). In this work, we developed a modular linker format for attaching molecular cargos to antibodies based on strand pairing between complementary oligonucleotides. We prepared antibody-oligonucleotide conjugates (AOCs) by attaching 18-mer oligonucleotides to an anti-HER2 antibody through thiol-maleimide chemistry, a method generally applicable to any immunoglobulin with interchain disulfide bridges. The hybridization of drug-bearing complementary oligonucleotides to our AOCs was rapid, stoichiometric, and sequence-specific. AOCs loaded with cytotoxic payloads were able to selectively target HER2-overexpressing cell lines such as SK-BR-3 and N87, with in vitro potencies similar to that of the marketed ADC Kadcyla (T-DM1). Our results demonstrated the potential of utilizing AOCs as a highly versatile and modular platform, where a panel of well-characterized AOCs bearing DNA, RNA, or various nucleic acid analogs, such as peptide nucleic acids, could be easily paired with any cargo of choice for a wide range of diagnostic or therapeutic applications.


Assuntos
Imunoconjugados/química , Oligonucleotídeos/química , Complexo Antígeno-Anticorpo , Antineoplásicos/química , Linhagem Celular Tumoral , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Imunoglobulina G/imunologia , Maitansina/química , Receptor ErbB-2/imunologia
4.
Angew Chem Int Ed Engl ; 55(40): 12338-42, 2016 09 26.
Artigo em Inglês | MEDLINE | ID: mdl-27580927

RESUMO

Siderophores, such as enterobactin (Ent), are small molecules that can be selectively imported into bacteria along with iron by cognate transporters. Siderophore conjugates are thus a promising strategy for delivering functional reagents into bacteria. In this work, we present an easy-to-perform, one-pot chemoenzymatic synthesis of functionalized monoglucosylated enterobactin (MGE). When functionalized MGE is conjugated to a rhodamine fluorophore, which affords RhB-Glc-Ent, it can selectively label Gram-negative bacteria that utilize Ent, including some E. coli strains and P. aeruginosa. V. cholerae, a bacterium that utilizes linearized Ent, can also be weakly targeted. Moreover, the targeting is effective under iron-limiting but not iron-rich conditions. Our results suggest that the RhB-Glc-Ent probe is sensitive not only to the bacterial strain but also to the iron condition in the environment.


Assuntos
Enterobactina/análogos & derivados , Escherichia coli/isolamento & purificação , Pseudomonas aeruginosa/isolamento & purificação , Proteínas de Bactérias/metabolismo , Cromatografia Líquida de Alta Pressão , Enterobactina/síntese química , Enterobactina/metabolismo , Escherichia coli/metabolismo , Glucosiltransferases/metabolismo , Glicosilação , Glicosiltransferases/metabolismo , Espectrometria de Massas , Microscopia , Pseudomonas aeruginosa/metabolismo , Rodaminas/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...